Frequent expression of the NPM-ALK chimeric fusion protein in anaplastic large-cell lymphoma, lympho-histiocytic type

被引:0
|
作者
Pileri, SA
Pulford, K
Mori, S
Mason, DY
Sabattini, E
Roncador, G
Piccioli, M
Ceccarelli, C
Piccaluga, PP
Santini, D
Leone, O
Stein, H
Falini, B
机构
[1] UNIV BOLOGNA,HEMATOPATHOL SECT,BOLOGNA,ITALY
[2] UNIV OXFORD,DEPT CELLULAR SCI,OXFORD,ENGLAND
[3] UNIV TOKYO,DEPT PATHOL,TOKYO,JAPAN
[4] FREE UNIV BERLIN,INST PATHOL,D-1000 BERLIN,GERMANY
[5] UNIV PERUGIA,INST HEMATOL,I-06100 PERUGIA,ITALY
来源
AMERICAN JOURNAL OF PATHOLOGY | 1997年 / 150卷 / 04期
关键词
D O I
暂无
中图分类号
R36 [病理学];
学科分类号
100104 ;
摘要
The revised European-American lymphoma classification recognizes a subtype of anaplastic large-cell lymphoma (ALCL), termed lympho-histiocytic because of its peculiar cytological composition. As in the case of classical ALCL, this tumor usually occurs in young patients and shows an excellent response to chemotherapy, but some authors have suggested that in reality this is a nonanaplastic T-cell lymphoma rich in histiocytes. In this paper, we show that three of five cases of lympbo-histiocytic ALCL stain with anti-ALK antibodies and can therefore be presumed to express the chimeric NPM/ALK protein secondary to (2;5) translocation. These findings further support the inclusion of this as a type of AI;CL and not among the nonanaplastic peripheral T-cell lymphomas. Furthermore, they indicate that staining for ALK proteins is a powerful tool for the diagnosis of lympho-histiocytic ALCL, the recognition of which may be difficult on morphological grounds.
引用
收藏
页码:1207 / 1211
页数:5
相关论文
共 50 条
  • [41] In vitro and in vivo antitumor activity of the selective ALK inhibitor ASP3026 against NPM-ALK plus T-cell anaplastic large-cell lymphoma
    Vishwannitra, Deeksha
    George, Suraj Konnath
    Manshouri, Roxsan
    Shi, Ping
    Amin, Hesham M.
    CANCER RESEARCH, 2014, 74 (20)
  • [42] IGF-IR tyrosine kinase interacts with NPM-ALK oncogene to induce survival of T-cell ALK+ anaplastic large-cell lymphoma cells
    Shi, Ping
    Lai, Raymond
    Lin, Quan
    Iqbal, Abid S.
    Young, Leah C.
    Kwak, Larry W.
    Ford, Richard J.
    Amin, Hesham M.
    BLOOD, 2009, 114 (02) : 360 - 370
  • [43] NPM-ALK phosphorylates WASp Y102 and contributes to oncogenesis of anaplastic large cell lymphoma
    C A Murga-Zamalloa
    V Mendoza-Reinoso
    A A Sahasrabuddhe
    D Rolland
    S R Hwang
    S R P McDonnell
    A P Sciallis
    R A Wilcox
    V Bashur
    K Elenitoba-Johnson
    M S Lim
    Oncogene, 2017, 36 : 2085 - 2094
  • [44] NPM-ALK Is a Key Regulator of the Oncoprotein FOXM1 in ALK-Positive Anaplastic Large Cell Lymphoma
    Haque, Moinul
    Li, Jing
    Huang, Yung-Hsing
    Almowaled, Meaad
    Barger, Carter J.
    Karpf, Adam R.
    Wang, Peng
    Chen, Will
    Turner, Suzanne D.
    Lai, Raymond
    CANCERS, 2019, 11 (08)
  • [45] NPM-ALK phosphorylates WASp Y102 and contributes to oncogenesis of anaplastic large cell lymphoma
    Murga-Zamalloa, C. A.
    Mendoza-Reinoso, V.
    Sahasrabuddhe, A. A.
    Rolland, D.
    Hwang, S. R.
    McDonnell, S. R. P.
    Sciallis, A. P.
    Wilcox, R. A.
    Bashur, V.
    Elenitoba-Johnson, K.
    Lim, M. S.
    ONCOGENE, 2017, 36 (15) : 2085 - 2094
  • [46] Involvement of Grb2 adaptor protein in nucleophosmin-anaplastic lymphoma kinase (NPM-ALK) mediated signaling and anaplastic large cell lymphoma growth
    Riera, L.
    Lasorsa, E.
    Ambrogio, C.
    Surrenti, N.
    Voena, C.
    EJC SUPPLEMENTS, 2010, 8 (07): : 112 - 112
  • [47] Involvement of Grb2 Adaptor Protein in Nucleophosmin-Anaplastic Lymphoma Kinase (NPM-ALK)-mediated Signaling and Anaplastic Large Cell Lymphoma Growth
    Riera, Ludovica
    Lasorsa, Elena
    Ambrogio, Chiara
    Surrenti, Nadia
    Voena, Claudia
    Chiarle, Roberto
    JOURNAL OF BIOLOGICAL CHEMISTRY, 2010, 285 (34) : 26441 - 26450
  • [48] INVOLVEMENT OF GRB2 ADAPTOR PROTEIN IN NUCLEOPHOSMIN-ANAPLASTIC LYMPHOMA KINASE (NPM-ALK) MEDIATED SIGNALING AND ANAPLASTIC LARGE CELL LYMPHOMA GROWTH
    Riera, L.
    Lasorsa, E.
    Ambrogio, C.
    Surrenti, N.
    Voena, C.
    Chiarle, R.
    HAEMATOLOGICA-THE HEMATOLOGY JOURNAL, 2010, 95 : 168 - 168
  • [49] ANAPLASTIC LARGE-CELL LYMPHOMAS EXPRESSING THE NOVEL CHIMERIC PROTEIN P80(NPM/ALK) - A DISTINCT CLINICOPATHOLOGICAL ENTITY
    SHIOTA, M
    NAKAMURA, S
    ICHINOHASAMA, R
    ABE, M
    AKAGI, T
    TAKESHITA, M
    MORI, N
    FUJIMOTO, J
    MIYAUCHI, J
    MIKATA, A
    NANBA, K
    TAKAMI, T
    YAMABE, H
    TAKANO, Y
    IZUMO, T
    NAGATANI, T
    MOHRI, N
    NASU, K
    SATOH, H
    KATANO, H
    FUJIMOTO, J
    YAMAMOTO, T
    MORI, S
    BLOOD, 1995, 86 (05) : 1954 - 1960
  • [50] ALK-negative anaplastic large-cell lymphoma
    Gaulard, Philippe
    de Leval, Laurence
    BLOOD, 2016, 127 (02) : 175 - +